Profiel
Jeff Kmetz worked as the Director of US Hematology Marketing at Alexion Pharmaceuticals, Inc. and as the Head of Commercial Development at Pharmacyclics LLC.
He also briefly served as the Chief Business Officer at Pulse Biosciences, Inc. in 2018.
Kmetz completed his undergraduate degree at Virginia Polytechnic Institute & State University.
Eerdere bekende functies van Jeff Kmetz
| Bedrijven | Functie | Einde |
|---|---|---|
| PULSE BIOSCIENCES, INC. | Corporate Officer/Principal | 01-11-2018 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Opleiding van Jeff Kmetz
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PULSE BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
